MARKET

MXCT

MXCT

Maxcyte
NASDAQ
2.270
-0.085
-3.61%
Closed 18:03 05/12 EDT
OPEN
2.420
PREV CLOSE
2.355
HIGH
2.469
LOW
2.230
VOLUME
1.01M
TURNOVER
0
52 WEEK HIGH
5.26
52 WEEK LOW
2.210
MARKET CAP
241.34M
P/E (TTM)
-5.7967
1D
5D
1M
3M
1Y
5Y
1D
MaxCyte’s Earnings Call: Navigating Challenges and Opportunities
TipRanks · 6h ago
Weekly Report: what happened at MXCT last week (0505-0509)?
Weekly Report · 23h ago
MaxCyte Files Form 10-Q for Q1 2025
TipRanks · 4d ago
Craig-Hallum Reaffirms Their Buy Rating on MaxCyte (MXCT)
TipRanks · 4d ago
Stifel Nicolaus Sticks to Its Buy Rating for MaxCyte (MXCT)
TipRanks · 4d ago
MaxCyte’s Strategic Growth and Stability: A Buy Rating by Analyst Mark Massaro
TipRanks · 4d ago
MaxCyte’s Strong Financial Performance and Growth Potential Justify Buy Rating
TipRanks · 5d ago
MaxCyte’s Strong Execution and Strategic Measures Earns Buy Rating Amid Market Challenges
TipRanks · 5d ago
More
About MXCT
More
MaxCyte, Inc. is a cell-engineering focused company providing solutions to advance the discovery, development and commercialization of cell therapeutics. It leverages its cell engineering technology platform to enable the programs of its biotechnology and pharmaceutical company customers who are engaged in cell therapy. Its ExPERT platform, which is based on its Flow Electroporation technology, is designed to support the expanding cell therapy market and can be utilized across the continuum of the cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes four instruments, the ATx, STx, GTx and VLx; a portfolio of proprietary related processing assemblies or disposables; and software protocols, all supported by a worldwide intellectual property portfolio. It also provides comprehensive off-target risk assessment solutions for gene editing, through ONE-seq and GUIDE-seq platforms.
Recently
Symbol
Price
%Change

Webull offers MaxCyte Inc stock information, including NASDAQ: MXCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MXCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MXCT stock methods without spending real money on the virtual paper trading platform.